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Abstract 
In this study, the effect of human erythropoietin (rhEPO) with aerobic exercise on the femur and humerus bone of 
female rats in the pubertal period was investigated by morphometric method. The study was performed on 40 
female rats of the Spraque – Dawley genus. 
The rats were divided into four groups as erythropoietin, swimming exercise with erythropoietin, swimming and 
sedentary. For 4 weeks, every other day all rats were injected with rhEPO (100 IU / kg, IP) 4 days a week. After 
the injection, the swimming group with rhEPO and the solo swimming group were swam for 30 minutes. At the 
end of 4 weeks, the rats were euthanized, and corpus, height and cortex and cavum medulla measurements of 
humerus and femur bones were done. 
Statistical evaluation also indicated that there were no differences (p>0.05) between rhEPO group, swimming 
group and rhEPO + swimming group femur length and femur cavum medulla da sedentary group. Sedentary group 
was found to be thicker (p<0.05) in femoral Corpus than swimming and rhEPO group, while there was no statistical 
difference in femoral cortex but a numerical difference was found. 
While Humerus bone length and Corpus were not significant in our study (p>0.05), although the numerical values 
of rhEPO + swimming group in Cortex and Cavum medullada were different compared to other groups, no 
statistical difference was found (p > 0.05). As a result, it is thought that long-term use of erythropoietin may cause 
bone development disorders. 
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1. Introduction 
It is well known that blood and bone share a unique, regulatory relationship with one another. But the details of 
the relationship between these two are still unanswered (McGee et al., 2012). Erythropoietin (EPO) is a 
hematopoietic growth factor that stimulates the formation of red blood cells. EPO is known as a doping agent in 
high-performance sports, and especially in cycling. In the clinical setting, this erythropoiesis stimulating agent is 
used to treat anemia, especially if it is caused by a lack of endogenous EPO production due to chronic kidney 
failure. In recent years, the non-hematopoietic functions of EPO, also known as pleiotropic functions, have been 
extensively investigated. Of interest for orthopedics and musculoskeletal tissue engineering, EPO's non-
hematopoietic capabilities include osteogenic and angiogenic potencies (Rölfing,  2014). 
For EPO's bone-forming role, the tissue may contain a protective hetereceptor ( Brines et al., 2004 ). However, 
Epo receptors ( Epo-R's) have been reported to be outside hematopoietic tissues, suggesting that EPO also plays a 
role in non-hematopoietic tissues (Mennini et al., 2006 ). The presence of Epo-R mRNAs has been reported in the 
brain, testes, placenta, heart, lungs, bone marrow and spleen ( Tan et al., 1991; Fandrey & Bunn, 1993; Agnello et 
al., 2002 ; Brines & Cerami, 2006 ). 
The differential role of EPO on different organs indicates tissue-specific functions of EPO (Haroon, et al., 2003 ). 
The finding that EPO has pleiotropic roles in non-hematopoietic tissues has led to research into the role of EPO in 
bone formation and homeostasis ( Li & Li, 2006; Wilson & Trumpp, 2006; Yin & Li, 2006 ). Therefore, combining 
hematopoiesis with skeletal homeostasis via Epo signaling makes important sense (Foldes et al., 1989 ; Gazit et 
al., 1990 ; Bab et al., 1992 ; Bab & Einhorn, 1993 ; Bab, 1995; Greenberg et al., 1995 ). In their studies, Lee et al., 
(1991) showed that Epo therapy can increase cortical thickness. 
Studies have repeatedly shown the morphological effect of EPO on bone, but the mechanisms that regulate the 
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process remain unclear. One suggestion is that EPO may play an important role in regenerating newly absorbed 
bone by stimulating JAK-STAT signaling pathways through Epo-R in HSCs ( Shiozawa et al., 2010 ). 
Among studies that observed bone formation in response to EPO, there are several notable major differences 
between those that did not. The first is the doses used. Supraphysiological doses are used in most studies showing 
bone formation. Those who used supraphysiological doses often used EPO doses that fell within a normal range. 
There may also be age-related differences in the animals ' response to EPO. We recorded that the reaction of young 
animals to EPO was more robust than the reaction in older animals (unpublished observations). Also, there are 
well-known differences in the hormonal response of different bones. For example, Singbrant et al. He studied the 
effects of EPO on the proximal tibia ( Singbrant et al., 2011 ).  
Recent and ongoing studies show that hematopoietic stimulation improves bone formation in the context of both 
early ossification and fraction recovery and advances in mechanical strength (Ferguson et al., 1999; Brager et al., 
2000; Bozler et al., 2006; Holstein et al., 2007). 
The debate about the effects of EPO on bone formation still needs to be resolved. Also, there is much to learn 
about the molecular mechanisms of EPO and bone formation; is EPO's effects on the skeleton coupled with 
hematopoiesis or secondary to EPO's effects on hematopoiesis? If there is a direct effect on the skeleton, the HSC 
or MSC is the target or both, and both activities need to be present simultaneously for bone formation to occur 
(McGee et al., 2012).text text text  text text 
 
2.Material And Method 
1- Subject Selection: 40 female Sprague-Dawley type rats from the Selçuk University Experimental Medicine 
Research and Application Center were used in the study. 
 Rats were housed in polycarbonate cages (Tecniplast, Italy) in a light-dark cycle of 14:10 hours at 21±2 0C, with 
1 rat in 250 cm2 area, adlibitum was fed with standard rat feed (Purina, Canada) and water (normal tap water in 
glass bottles). The study was continued for 4 weeks. 
Forming groups: the groups in the study were formed as follows. 
1. Group (Drug Trial Group, n=10). RhEPO for four weeks (EPOBEL ® 2000 IU / 0.6 mL LV, Nobel 
Pharmaceutical Marketing & Industries Ltd. Şti) 100 IU / kg (Nuno et al 2009) dose was applied 4 times per week 
in peritoneal and 30 min swimming exercise was performed after each drug application. 
2.  Group (Swimming control group, n=10): rats were fed normally, given peritoneal saline 4 times per week and 
30 min swimming exercise after each drug application. 
3. Group (Drug Control Group, n=10). RhEPO was administered 4 times peritoneal times per week at a dose of 
100 IU/kg for four weeks. 
4. Group (healthy control group, n = 10): the rats were fed normally. 
At the end of the fourth week, the rats were euthanized by intraperitoneal injection of 200 mg/kg (Pentotal 
sodium, Abbott) of pentobarbital. The anterior and posterior extremities of the materials were then uncovered and 
dissected and subjected to maceration. The uncovered humerus and femur bones were marked and preserved in 
special plastic bags. Morphometric measurements of height length, Corpus, cortex and cavum medulla of humerus 
and femur bones, diameter were made from the reference points shown in figures 2.1 and 2.2. Measurements were 
taken with a stainless hardened digital caliper (China) caliper of 0-100 mm. 
The images of the bones were taken with the Nikon DSLR D200. The statistical evaluation of the data 
was based on the package program SPSS 13.0 (SPSS 13.0 for Windows/ SPSS® Inc, Chicago, USA). The results 
were presented as mean±Sd. Anova and Duncan test were used to compare the data between groups. p<0.05 value 
was considered statistically significant. 
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Picture 2.1. Reference points of length (L), Corpus (C), Cortex (C1-C2) and Medullar diameters (M) of 
humerus 
      
L: dWstance between endpoWnts of Caput 
humer and trochlea humer.C: corpus of 
humerus thWckness (lower border level of 
TuberosWtas deltoWdea). 
C1 - C2: mean cortex thWckness (cortWcal 
bonesubstantWa) at the corpus level of the humerus 
compacta). 
M: dWameter of cavum medullare at the corpus 
level of humerus. 
Pictures 2.2. Reference points of femur length (L), Corpus (C), Cortex (C1-C2) and Medullar diameters (M) 
  
L: dWstance between caput ossWs femorWs and 
endpoWnts of trochlea ossWs femorWs. 
C: thWckness of the femur's corpus (lower bound 
level of the Trochanter TertWus). 
C1-C2: the mean cortex thWckness at the corpus 
level of the femur (cortWcal bone substantWa 
compacta). 
M: dWameter of cavum medullare at corpus level of 
femur. 
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3. Results 
Tab. 1.  
Morphometric Effect of Erythropoietin Used as Swimming Exercise and Doping on Humerus and Femur Bones 
in Female Puberty Period (mm) (Mean ± Sd). 
 rhEPO rhEPO + 
SwWmmWng  
SwWmmWng Sedentary F P 
Corpus 
FemorWs 
3.93 ± .14b 4.02 
± .18ab 
3.90 ± .19b 4.16 ± .15a 5.075 .005* 
Femur Length 30.63 
± .39 
31.02 
± .99 
30.36 ± 1.03 30.84 
± .39 
1.389 .262 
Femur Cortex .83 ± .11 .88 ± .12 .93 ± .14 .95 ± .09 2.163 .109 
Femur Cavum 
Medulla 
2.62 ± .21 2.28 ± .21 2.05 ± .38 2.24 ± .18 1.664 .192 
Corpus HumerW 2.94 ± .13 2.95 ± .08 2.86 ± .11 2.93 ± .23 .807 .498 
Humerus 
Length 
24.17 
± .40 
24.32 
± .66 
24.02 ± .46 24.27 
± .52 
.672 .575 
Humeral 
Cortex 
.77 ± .11 .82 ± .09 .75 ± .11 .76 ± .08 1.042 .386 
Humerus 
Cavum 
Medulla 
1.37 ± .26 1.33 ± .18 1.37 ± .20 1.45 ± .24 .513 .676 
* P <0.05. a, b, c, There are significant differences between values carrying different letters in the same line (p 
<0.05) 
 
              
Grafic1. Morphometric effect of erythropoietin on humerus and Femur Bones (mm) (Mean±Sd) used as 
swimming exercise and Doping in female rats during Puberta period. 
it is stated that there are no differences (p>0.05) between rhEPO group, swimming group and rhEPO + 
swimming group femur length, femur cavum medulla da sedentary group. Sedentary group was found to be thicker 
(p<0.05) in femoral Corpus than swimming and rhEPO Grun, but no statistical difference was found in femoral 
cortex. 
While Humerus bone length and Corpus were not significant in our study (p>0.05), although the 
numerical values of rhEPO + swimming group in Cortex and Cavum medullada were different compared to other 
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groups, no statistical difference was found (p > 0.05). 
4.Discussion 
The bone that forms the basis of skeletal mobility is a dynamic organ that plays a variety of roles in the 
body ( Anjos-Afonso & Bonnet, 2007 ). EPO bone creation may also include a hetereceptor that protects tissue 
(Brines, et al., 2004 ). EPO supplementation may increase cortical thickness in bone (Lee et al., 1991 ). EPO can 
improve bone formation (Ferguson et al., 1999; Brager et al., 2000; Bozler et al., 2006; Holstein et al., 2007). In 
their study, Sakunya et al., (2019) states that EPO therapy makes thickening in the corpus by regulating low bone 
mass in long bones. In our study, it was determined that the sedentary group was thicker (p<0.05) in femoral 
Corpus than in swimming and rhEPO group, while there was no statistical difference in femoral cortex but a 
numerical difference was found. Özdemir, (2013) reports that the widest corpus femoris (p<0.05) measurement 
was determined in the sedentary group.  
In another study, Röfling, (2014) in his study on bone fracture recovery in mice, states that EPO increases 
bone volume and decreases bone marrow cavity. After methanolone enanthate application to adolescent rats, 
Bozkurt et al., (2011) found that there was a significant (p<0.05) thinning of the corpus femorist while finding that 
there was a significant (p < 0.05) shortening of the femur length. 
In our study, the length and Corpus of humerus bone were not significant (p>0.05), although the numerical 
values of rhEPO + swimming group in Cortex and Cavum medullada were different compared to other groups, no 
statistical difference was found (p>0.05). In their study, Lavoie et al., (1998) examined the effect of anaerobic 
exercise on rat metabolism by using rhEPO supplementation and found that rhEPO contributes to bone tissue in a 
low proportion. Mohammadian et al., (2003) noted that the increase in iron load made growth retardation in bone 
particularly apparent in the age of puberta. Similarly, Low., (1997) stated that it inhibits growth in bone in his study 
looking at growth functions in beta-thalassemia patients.  
Low bone mineral density in some elite athletes suggests that intense exercise may have negative effects 
(Hatun, 2000). There are studies that show that high intensity exercises performed before and during puberta have 
positive or negative effects on growth and skeletal development. Studies on this subject show that girls with 
rhythmic gymnastics are shorter and weaker than their peers in other sports and non-sports (Benardot & Czerwinski 
1991, Damsgaard et al., 2000). Akin et al., (2004) reported that in their study with rhythmic gymnasts before 
puberta, intense exercise is shortening in the neck of gymnasts and thinning in bone thickness. 
5.Conclusion 
As a result, while rhEPO, commonly used as a doping agent in recent years, not only improves 
performance but provides positive effects in bone forty repairs in the long term, its negative effects on healthy 
bone tissue have been tried to be explained by rat models. Although the effects of rhEPO and intense exercise on 
bone development have not been demonstrated, further studies are needed to reveal their effects on other organs.   
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Tab. 1.  
Morphometric Effect of Erythropoietin Used as Swimming Exercise and Doping on Humerus and Femur Bones 
in Female Puberty Period (mm) (Mean ± Sd). 
 rhEPO rhEPO + 
SwWmmWng  
SwWmmWng Sedentary F P 
Corpus 
FemorWs 
3.93 ± .14b 4.02 
± .18ab 
3.90 ± .19b 4.16 ± .15a 5.075 .005* 
Femur Length 30.63 
± .39 
31.02 
± .99 
30.36 ± 1.03 30.84 
± .39 
1.389 .262 
Femur Cortex .83 ± .11 .88 ± .12 .93 ± .14 .95 ± .09 2.163 .109 
Femur Cavum 
Medulla 
2.62 ± .21 2.28 ± .21 2.05 ± .38 2.24 ± .18 1.664 .192 
Corpus HumerW 2.94 ± .13 2.95 ± .08 2.86 ± .11 2.93 ± .23 .807 .498 
Humerus 
Length 
24.17 
± .40 
24.32 
± .66 
24.02 ± .46 24.27 
± .52 
.672 .575 
Humeral 
Cortex 
.77 ± .11 .82 ± .09 .75 ± .11 .76 ± .08 1.042 .386 
Humerus 
Cavum 
Medulla 
1.37 ± .26 1.33 ± .18 1.37 ± .20 1.45 ± .24 .513 .676 
* P <0.05. a, b, c, There are significant differences between values carrying different letters in the same line (p 
<0.05) 
 
            
Grafic1. Morphometric effect of erythropoietin on humerus and Femur Bones (mm) (Mean±Sd) used as 
swimming exercise and Doping in female rats during Puberta period. 
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